Preview

Russian Journal of Pediatric Hematology and Oncology

Advanced search

Secretory diarrhea as paraneoplastic syndrome in neuroblastoma

https://doi.org/10.17650/2311-1267-2018-5-4-105-112

Abstract

Secretory diarrhea (SD) due to increased production of vasoactive intestinal peptide (VIP) in neuroblastoma (NB) is a rare paraneoplastic syndrome (PNS). Depending on the time of development of SD in relation to the diagnosis of NB, primary and secondary hypersecretion of VIP is distinguished. It is difficult to diagnose NB in the debut of a disease in a child with diarrhea as the main symptom, given that diarrhea is one of the most common syndromes found in pediatric practice and characteristic of acute intestinal infections, especially in young children. However, long-term SD in a child is an indication for screening for a neurogenic tumor. This article describes 2 clinical cases of PNS in patients with NB in the form of SD, which developed before the diagnosis of a malignant neoplasm, and at the stage of special treatment, as well as a review of the literature.

Conflict of interest. The authors declare no conflict of interest.

Funding. The study was performed without external funding.

About the Authors

G. B. Sagoyan
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Pediatric Oncologist Department of Clinical Oncology


M. Sh. Shingarova
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Resident doctor in the specialty “Pediatrics”


T. V. Shamanskaya
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Cand. of Sci. (Med.), Scientific Secretary of the Institute of Oncology, Radiology and Nuclear Medicine


D. G. Akhaladze
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Cand. of Sci. (Med.), Pediatric Surgeon Department of Oncology and Pediatric Surgery


N. N. Merkulov
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Pediatric Surgeon Department of Oncology and Pediatric Surgery


R. A. Moiseenko
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Pediatric Oncologist, Department of Clinical Oncology


N. G. Uskova
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Pediatric Surgeon Department of Oncology and Pediatric Surgery


V. Yu. Roshchin
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Pathologist Department of Pathological Anatomy


E. S. Ternovaya
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Physician Radiology Department


A. N. Novikov
Volgograd Regional Clinical Oncologic Dispensary
Russian Federation
Pediatric Oncologist/Surgeon Children’s Department


I. V. Fisyun
Scientific and Clinical Multidisciplinary Center of Medical Care for Mothers and Children named after Z.I. Kruglaya
Russian Federation
Head of the Department of Pediatric Oncology and Hematology


D. Yu. Kachanov
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Dr. of Sci. (Med.), Head of the Department of Clinical Oncology, Deputy Director of the Institute of Oncology, Radiology and Nuclear Medicine


S. R. Varfolomeeva
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Dr. of Sci. (Med.), Professor, Deputy General Director – Director of the Institute of Management and Translational Medicine


References

1. Maris J.M. Recent advances in neuroblastoma. N Engl J Med 2010;362(23):2202–11. doi: 10.1056/NEJMra0804577.

2. Goodman M.S., Gurney J.G., Smith M.A., Olshan A.F. Sympathetic nervous system tumors. In: Ries L.A.G., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L. Jr, Bunin G.R., eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975– 1995. National Cancer Institute, SEER Program. Bethesda, MD, 1999. Pp. 65–72.

3. Spix C., Pastore G., Sankila R., Stiller C.A., Steliarova-Foucher E. Neuroblastoma incidence and survival in European children (1978– 1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42(13):2081–91. doi: 10.1016/j.ejca.2006.05.008.

4. Геворков А.Р. Паранеопластические синдромы. В кн.: Онкология: национальное руководство. Под ред. В.И. Чиссова, М.И. Давыдова. М.: ГЭОТАР-Медиа, 2008. С. 547–570. [Gevorkov A.R. Paraneoplastic syndromes. In: Oncology: National guidelines. Edited by V.I. Chissov, M.I. Davydov. M.: GEOTAR-Media, 2008. Pp. 547–570. (In Russ.)].

5. Качанов Д.Ю., Шаманская Т.В., Малевич О.Б., Варфоломеева С.Р. Синдром опсоклонус-миоклонус и нейробластома (обзор литературы). Российский журнал детской гематологии и онкологии 2014;1(1):62–9. doi: 10.17650/2311-1267-2014-0-1-62-69. [Kachanov D.Yu., Shamanskaya T.V., Malevich O.B., Varfolomeeva S.R. Opsoclonusmyoclonus syndrome and neuroblastoma (a review of literature). Rossiyskiy zhurnal detskoy gematologii i onkologii = Russian Journal of Pediatric Hematology and Oncology 2014;1(1):62–9. doi: 10.17650/2311-1267-2014-0-1-62-69. (In Russ.)].

6. Qureshi S.S., Bhagat M., Anam J., Vora T. Aggressive cervical neuroblastoma with a rare paraneoplastic syndrome: A therapeutic dilemma. J Indian Assoc Pediatr Surg 2016;21(4):181–3. doi: 10.4103/0971-9261.186548.

7. Bourdeaut F., de Carli E., Timsit S., Coze C., Chastagner P., Sarnacki S., Delattre O., Peuchmaur M., Rubie H., Michon J.; Neuroblastoma Committee of the Société Française des Cancers et Leucémies de l’Enfant et de l’Adolescent. VIP Hypersecretion as Primary or Secondary Syndrome in Neuroblastoma: A Retrospective Study by the Société Française des Cancers de l’Enfant (SFCE). Pediatr Blood Cancer 2009;52(5):585–90. doi: 10.1002/pbc.21912.

8. Farthing M., Salam M., Lindberg G., Dite P., Khalif I., Salazar-Lindo E., Ramakrishna B.S., Goh K., Thomson A., Khan A.G., Krabshuis J., LeMair A. Acute diarrhea in adults and children: a global perspective. World Gastroenterology Organisation Global Guidelines, 2012. [Electronic resource]: http://www. worldgastroenterology.org/UserFiles/fi le/guidelines/acute-diarrheaenglish-2012.pdf (appeal date 20.09.2018).

9. Verner J.V., Morrison A.B. Islet cell tumor and a syndrome of refractory watery diarrhoea and hypokalemia. Am J Med 1958;25:374–80. PMID: 13571250.

10. Green M., Cooke R.E., Lattanzi W. Occurrence of chronic diarrhea in three patients with ganglioneuromas. Pediatrics 1959;23(5):951–5. PMID: 13645132.

11. Balemba O.B., Grondahl M.L., Mbassa G.K., Semuguruka W.D., HaySmith A., Skadhauge E., Dantzer V. The organization of the enteric nervous system in the submucous and mucous layers of the small intestine of the pig studied by VIP and neurofi lament protein immunohistochemistry. J Anat 1998;192(Pt 2):257–67. doi: 10.1046/j.1469-7580.1998.19220257.x.

12. Pincus D.W., DiCicco-Bloom E.M., Black I.B. Vasoactive intestinal peptide regulates mitosis, diff erentiation and survival of cultured sympathetic neuroblasts. Nature 1990;343(6258):564–7. doi: 10.1038/343564a0.

13. Tiedemann K., Long R.G., Pritchard J., Bloom S.R. Plasma vasoactive intestinal polypeptide and other regulatory peptides in children with neurogenic tumours. Eur J Pediatr 1981;137(2):147–50. PMID: 7308225.

14. Tiedemann K., Pritchard J., Long R., Bloom S.R. Intractable diarrhea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Attempted control by somatostatin. Eur J Pediatr 1981;137(2):217–9. PMID: 6118274.

15. Adam N., Lim S.S., Ananda V., Chan S.P. VIPoma syndrome: challenges in management. Singapore Med J 2010;51(7):e129–32. PMID: 20730389.

16. Kabalan P., Giff ord A.J., Ziegler D.S. Unresectable VIP-secreting neuroblastoma: Effi cacy of debulking and steroids for symptom control. Pediatr Blood Cancer 2018;65(12):e27358. doi: 10.1002/pbc.27358.


Review

For citations:


Sagoyan G.B., Shingarova M.Sh., Shamanskaya T.V., Akhaladze D.G., Merkulov N.N., Moiseenko R.A., Uskova N.G., Roshchin V.Yu., Ternovaya E.S., Novikov A.N., Fisyun I.V., Kachanov D.Yu., Varfolomeeva S.R. Secretory diarrhea as paraneoplastic syndrome in neuroblastoma. Russian Journal of Pediatric Hematology and Oncology. 2018;5(4):105-112. (In Russ.) https://doi.org/10.17650/2311-1267-2018-5-4-105-112

Views: 1139


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2311-1267 (Print)
ISSN 2413-5496 (Online)
X